Der kranke/auffällige rechte Ventrikel

Die Funktion des rechten Herzens spielt eine prognostisch entscheidende Rolle bei Patienten mit kardiopulmonalen Erkrankungen. Eine Rechtsherzinsuffizienz besteht meistens als Folge einer Linksherzinsuffizienz, die Behandlung richtet sich dann nach dieser. Eine isolierte Erkrankung des rechten Herzens ist hingegen selten. Gegenwärtige Empfehlungen zur Herangehensweise und Abklärung eines „erkrankten rechten Ventrikels“ sind unzureichend.

Schlüsselwörter

Rechtsherzinsuffizienz - rechter Ventrikel - pulmonale Hypertonie - Cor pulmonale

• Literatur

• 1 Sanz J, Sánchez-Quintana D, Bossone E. et al. Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73: 1463-1482
• 2 Zong P, Tune JD, Downey HF. Mechanisms of oxygen demand/supply balance in the right ventricle. Exp Biol Med 2005; 230: 507-519
• 3 Galiè N, Humbert M, Vachiery JL. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37: 67-119
• 4 Vahanian A, Beyersdorf F, Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561-632
• 5 Aquaro GD, Negri F, de Luca A. et al. Role of right ventricular involvement in acute myocarditis, assessed by cardiac magnetic resonance. Int J Cardiol 2018; 271: 359-365
• 6 Möllmann H, von Bardeleben RS, Dreger H. et al. Trikuspidalklappeninsuffizienz, DGK-Positionspapier. Kardiologie 2022; 16: 372-382
• 7 Topilsky Y, Khanna A, le Toumeau T. et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 2012; 5: 314-323
• 8 Soliman OII, Akin S, Muslem R. et al. Derivation and validation of a novel right-sided heart failure model after implantation of continuous flow left ventricular assist devices. Circulation 2018; 137: 891-906
• 9 Rösner A, Avenarius D, Malm S. et al. Changes in Right Ventricular Shape and Deformation Following Coronary Artery Bypass Surgery – Insights from Echocardiography with Strain Rate and Magnetic Resonance Imaging. Echocardiography 2015; 32: 1809-1820
• 10 Konstam MA, Kiernan MS, Bernstein D. et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2018; 137: e578-e622
• 11 Graham TP, Bernard YD, Mellen BG. et al. Long-term outcome in congenitally corrected transposition of the great arteries. J Am Coll Cardiol 2000; 36: 255-261
• 12 Chang WT, Shih JY, Hong CS. et al. Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension. ESC Heart Fail 2021; 8: 3082-3092
• 13 Surkova E, Cosyns B, Gerber B. et al. The dysfunctional right ventricle: the importance of multi-modality imaging. Eur Heart J Cardiovasc Imaging 2022; 23: 885-897
• 14 Amsallem M, Kuznetsova T, Hanneman K. et al. Right heart imaging in patients with heart failure: A tale of two ventricles. Curr Opin Cardiol 2016; 31: 469-482
• 15 Wang TKM, Jellis C. The Role of Multimodality Imaging in Right Ventricular Failure. Cardiol Clin 2020; 38: 203-217
• 16 Mebazaa A, Motiejunaite J, Gayat E. et al. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail 2018; 20: 332-341
• 17 Hansen MS, Andersen A, Nielsen-Kudsk JE. Levosimendan in pulmonary hypertension and right heart failure. Pulm Circ 2018; 8: 2045894018790905
• 18 Soliman OII, Akin S, Muslem R. et al. Derivation and validation of a novel right-sided heart failure model after implantation of continuous flow left ventricular assist devices. Circulation 2018; 137: 891-906
• 19 Lester SJ, McElhinney DB, Viloria E. et al. Effects of Losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol 2001; 88: 1314-1316
• 20 Beck-da-Silva L, de Bold A, Davies R. et al. Effect of bisoprolol on right ventricular function and brain natriuretic peptide in patients with heart failure. Congest Heart Fail 2004; 10: 127-132
• 21 van der Bom T, Winter MM, Bouma BJ. et al. Effect of valsartan on systemic right ventricular function: A double-blind, randomized, placebo-controlled pilot trial. Circulation 2013; 127: 322-330
• 22 van Dissel AC, Winter MM, van der Bom T. et al. Long-term clinical outcomes of valsartan in patients with a systemic right ventricle: Follow-up of a multicenter randomized controlled trial. Int J Cardiol 2019; 278: 84-87
• 23 Zandstra TE, Nederend M, Jongbloed MRM. et al. Sacubitril/valsartan in the treatment of systemic right ventricular failure. Heart 2021; 107: 1725
• 24 Codina P, Domingo M, Barceló E. et al. Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension. ESC Heart Fail 2022; 9: 2170-2180
• 25 Clements RT, Vang A, Fernandez-Nicolas A. et al. Treatment of Pulmonary Hypertension with Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan. Circ Heart Fail 2019; 12: e005819
• 26 Frantz RP, Desai S, Ewald G. et al. First Results of Soprano: Macitentan in Patients (pts) with Pulmonary Hypertension (PH) Post-Left Ventricular Assist Device (LVAD) Implantation. J Heart Lung Transplant 2021; 40: S12-S13
• 27 Janoušek J, Kovanda J, Ložek M. et al. Pulmonary right ventricular resynchronization in congenital heart disease: Acute improvement in right ventricular mechanics and contraction efficiency. Circ Cardiovasc Imaging 2017; 10: e006424
• 28 Rasmussen JT, Thenappan T, Benditt DG. et al. Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?. Pulm Circ 2014; 4: 552-559